Biocon Q2 Results | Syngene, Biocon’s research services division, reported Q2 revenue of ₹891 crore, down 2% YoY, but up 13% on a sequential basis. Shares of Biocon Ltd ended at ₹320.80, down by ₹6.05, or 1.85%, on the BSE.
Biocon Q2 Results | Syngene, Biocon’s research services division, reported Q2 revenue of ₹891 crore, down 2% YoY, but up 13% on a sequential basis. Shares of Biocon Ltd ended at ₹320.80, down by ₹6.05, or 1.85%, on the BSE.